Also trades as: GLENMARK.BO (BSE) · $vol 1M
GLENMARK.NS NSE
Glenmark Pharmaceuticals Limited
1W: -4.1%
1M: -5.6%
3M: +5.4%
YTD: +19.1%
1Y: +15.0%
3Y: +187.3%
5Y: +302.6%
₹2,326.10 ($24.17)
-4.90 (-0.21%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
📊 Key Metrics
TTM₹170B
Revenue
+27.8% YoY
₹14B
Net Income
+30.1% YoY
₹20B
Free Cash Flow
+260.4% YoY
41.5%
Gross Margin
16.3%
Op. Margin
8.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE14.1%
ROA7.6%
ROIC23.6%
Valuation
P/E36.6
P/B6.3
EV/EBITDA21.5
Leverage
Debt/Equity0.06
Current Ratio1.77
Interest Cov.10.5x
Quality Scores
Piotroski F8/9
Altman Z6.05
Beneish M-2.30